KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Common Equity (2016 - 2026)

Silicon Laboratories has reported Common Equity over the past 17 years, most recently at $1.1 billion for Q1 2026.

  • Quarterly results put Common Equity at $1.1 billion for Q1 2026, up 1.33% from a year ago — trailing twelve months through Jan 2026 was $1.1 billion (up 1.33% YoY), and the annual figure for FY2026 was $1.1 billion, up 1.33%.
  • Common Equity for Q1 2026 was $1.1 billion at Silicon Laboratories, up from $1.1 billion in the prior quarter.
  • Over the last five years, Common Equity for SLAB hit a ceiling of $2.2 billion in Q1 2022 and a floor of $1.1 billion in Q3 2025.
  • Median Common Equity over the past 5 years was $1.2 billion (2023), compared with a mean of $1.3 billion.
  • Peak annual rise in Common Equity hit 84.39% in 2022, while the deepest fall reached 41.39% in 2022.
  • Silicon Laboratories' Common Equity stood at $1.4 billion in 2022, then dropped by 13.97% to $1.2 billion in 2023, then dropped by 10.64% to $1.1 billion in 2024, then fell by 0.86% to $1.1 billion in 2025, then increased by 2.21% to $1.1 billion in 2026.
  • The last three reported values for Common Equity were $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025) per Business Quant data.